Masterclasses
Mood disorders often present with diagnostic challenges, comorbidities, and treatment resistance, making clinical decision-making complex. This expert-led masterclass provides practical, case-based learning to enhance psychiatrists’ ability to diagnose, manage, and personalize treatment plans for patients with bipolar disorder, atypical depression, and complex mood presentations.This masterclass is designed for psychiatrists seeking evidence-based, practical strategies to navigate the complexities of mood disorders in everyday practice.
Following this masterclass, your Case Discussion Forum comes in to help you master the skills you learned and applied. A 90-minute, live case discussion is included with your masterclass registration and offers a chance to consolidate learning through real-world clinical application.Led by Dr Mourad Wahba, the session invites participants to present or discuss cases involving treatment-resistant depression, suicidality, bipolar features, or overlapping neurodevelopmental issues. Through guided discussion and peer learning, you’ll strengthen your clinical decision-making in complex mood presentations.
💬 Not attending the masterclass?
You can still join the case discussion forum as a standalone learning opportunity — just select the Complex Mood Disorders forum at checkout.
By the end of this masterclass, participants will be able to:
Consultant Psychiatrist and Honorary Senior Clinical Lecturer at Newcastle University
Dr. Mourad Wahba (MBChB, MRCPsych) is a Consultant Psychiatrist and Honorary Senior Clinical Lecturer at Newcastle University specialising in mood disorders and clinical research delivery. With extensive clinical and research experience, Dr. Wahba co-leads the Care Pathway Enhancement Clinic, a specialist mood disorder research clinic which supports patients with complex mood disorders in the community and facilitates delivery of novel and innovative treatment approaches through research involvement.
With a keen interest in psychedelic therapy, Dr. Wahba is Principal Investigator for several Phase 3 clinical trials utilising psychedelics for psychiatric disorders including Major Depressive Disorder, Anxiety, and Treatment Resistant Depression, positioning him at the forefront of psychiatric research and psychedelic-assisted therapy. He has also contributed as a sub-investigator in several clinical trials published in leading journals, including the New England Journal of Medicine and the British Journal of Psychiatry.
Otherwise, Dr. Wahba holds a Postgraduate Certificate in Clinical Research Delivery (Distinction) and is an Approved Clinician in the UK, reflecting his commitment to evidence-based practice and clinical excellence. An experienced educator, he actively teaches medical students, psychiatry trainees, and healthcare professionals, while also engaging in public education and mental health advocacy.
